Literature DB >> 3294892

Tissue homogenization with sterile reinforced polyethylene bags for quantitative culture of Candida albicans.

T J Walsh, C McEntee, D M Dixon.   

Abstract

A simple method of tissue homogenization with sterile reinforced polyethylene bags for quantitative fungal cultures was evaluated with mice infected with Candida albicans. This new method correlated well with standard methods (P less than or equal to 0.01) for quantifying viable fungus in homogenates of brain, kidney, spleen, liver, and lungs and may be applicable in clinical and experimental mycology laboratories.

Entities:  

Mesh：

Year:  1987        PMID： 3294892      PMCID： PMC266122          DOI： 10.1128/jcm.25.5.931-932.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  The zygomycete Saksenaea vasiformis as a pathogen of humans with a critical review of the etiology of zygomycosis.

Authors:  L Ajello; D F Dean; R S Irwin
Journal:  Mycologia       Date:  1976 Jan-Feb       Impact factor: 2.696

Review 2.  Opportunistic mycotic osteomyelitis: bone infections due to Aspergillus and Candida species.

Authors:  M B Simpson; W G Merz; J P Kurlinski; M H Solomon
Journal:  Medicine (Baltimore)       Date:  1977-11       Impact factor: 1.889

3.  Isolation of cladosporium trichoides from nature.

Authors:  D M Dixon; H J Shadomy; S Shadomy
Journal:  Mycopathologia       Date:  1977-12-16       Impact factor: 2.574

4.  Disseminated zygomycosis (mucormycosis) caused by Saksenaea vasiformis.

Authors:  R J Hay; C K Campbell; W M Marshall; B I Rees; J Pincott
Journal:  J Infect       Date:  1983-09       Impact factor: 6.072

5.  Nosocomial invasive Saksenaea vasiformis infection.

Authors:  A D Oberle; R L Penn
Journal:  Am J Clin Pathol       Date:  1983-12       Impact factor: 2.493

6.  Closure of osteomyelitic and traumatic defects of the leg by muscle and musculocutaneous flaps.

Authors:  E T James; J S Gruss
Journal:  J Trauma       Date:  1983-05

7.  Microvascular transfer of free tissue for closure of bone wounds of the distal lower extremity.

Authors:  J W May; G G Gallico; F N Lukash
Journal:  N Engl J Med       Date:  1982-02-04       Impact factor: 91.245

8.  In vivo studies with ambruticin in murine histoplasmosis.

Authors:  S Shadomy; C J Utz; S White
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

9.  Disseminated Saksenaea vasiformis infection.

Authors:  J Torell; B H Cooper; N G Helgeson
Journal:  Am J Clin Pathol       Date:  1981-07       Impact factor: 2.493

10.  Dematiaceous fungal pathogens isolated from nature.

Authors:  D M Dixon; H J Shadomy; S Shadomy
Journal:  Mycopathologia       Date:  1980-03-31       Impact factor: 2.574
View more
  35 in total

1.  Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.

Authors:  T J Walsh; C E Gonzalez; S Piscitelli; J D Bacher; J Peter; R Torres; D Shetti; V Katsov; K Kligys; C A Lyman
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Use of a mouse model to evaluate clinical and environmental isolates of Sporothrix spp. from the largest U.S. epidemic of sporotrichosis.

Authors:  D M Dixon; R A Duncan; N J Hurd
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

3.  Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia.

Authors:  Ruta Petraitiene; Vidmantas Petraitis; Andreas H Groll; Tin Sein; Robert L Schaufele; Andrea Francesconi; John Bacher; Nilo A Avila; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

4.  Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.

Authors:  V Petraitis; R Petraitiene; A H Groll; T Sein; R L Schaufele; C A Lyman; A Francesconi; J Bacher; S C Piscitelli; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

5.  Induction and expression of cell-mediated immune responses in inbred mice infected with Coccidioides immitis.

Authors:  R A Cox; W Kennell; L Boncyk; J W Murphy
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

6.  Microbiology and potential virulence of Sporothrix cyanescens, a fungus rarely isolated from blood and skin.

Authors:  L Sigler; J L Harris; D M Dixon; A L Flis; I F Salkin; M Kemna; R A Duncan
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

7.  Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans.

Authors:  Vidmantas Petraitis; Ruta Petraitiene; Amy M Kelaher; Alia A Sarafandi; Tin Sein; Diana Mickiene; John Bacher; Andreas H Groll; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

8.  Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits.

Authors:  V Petraitis; R Petraitiene; A H Groll; A Bell; D P Callender; T Sein; R L Schaufele; C L McMillian; J Bacher; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

9.  Development and validation of a quantitative real-time PCR assay using fluorescence resonance energy transfer technology for detection of Aspergillus fumigatus in experimental invasive pulmonary aspergillosis.

Authors:  Cathal E O'Sullivan; Miki Kasai; Andrea Francesconi; Vidmantas Petraitis; Ruta Petraitiene; Amy M Kelaher; Alia A Sarafandi; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

10.  Antifungal effects of the nonlinear pharmacokinetics of cilofungin, a 1,3-beta-glucan synthetase inhibitor, during continuous and intermittent intravenous infusions in treatment of experimental disseminated candidiasis.

Authors:  T J Walsh; J W Lee; P Kelly; J Bacher; J Lecciones; V Thomas; C Lyman; D Coleman; R Gordee; P A Pizzo
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.